|  | Panther Classifications3 | D.A.V.I.D. Functional Annotation4 |
---|---|---|---|
 |  | • Pathway (P value) | • Category |
 |  | • Biological Process (P value) | • Term |
Network and Central Node(s)1 | Ingenuity Annotations2 | • Molecular Function (P value) | • P value |
Network 1 FOS and IL1A | • Immune response | • Inflammation mediated by chemokine and cytokine signaling (6.0E-5) | • GOTERM_BP_ALL |
 | • Connective tissue disorders |  | • Defense response |
 | • Inflammatory disease |  | • 7.7E-11 |
 | • Immunity and defense | • Cytokine receptor (1.5E-09) |  |
Network 2 MAPK1 | • Cellular movement | • Toll receptor signaling pathway (4.0E-10) | • SP_PIR_KEYWORDS |
 | • Hematologic system |  | • Signal |
 | Development | • Proteolysis (2.9E-12) | • 1.3E-9 |
 | • Immune response | • Serine protease (3.6E-9) |  |
Network 3 SP1 | • Inflammatory disease | • Plasminogen activating cascade (3.3E-4) | • SP_PIR_KEYWORDS |
 | • Hematologic system development |  | • Direct protein sequencing |
 |  | • Immunity and defense (3.2E-8) | • 2.7E-9 |
 | • Immune response | • Complement component (3.8E-5) |  |
Network 4 STAT3 and STAT5 | • Cellular movement | • PDGF signaling pathway (1.4E-10) | • SP_PIR_KEYWORDS |
 | • Cell morphology |  | • Phosphorylation |
 | • Cellular function and | • Signal transduction (1.2E-16) maintenance | • 2.2E-14 |
 |  | • Non-receptor tyrosine protein kinase (2.6E-09) |  |
Network 5 NFKB1A | • Cell death | • Insulin/IGF pathway-protein kinase B signaling pathway (1.7E-7) | • GOTERM_MF_ALL |
 | • Cancer |  | • Protein binding |
 | • Hematologic disease | • Apoptosis (2.5E-8) | • 1.4E-9 |
 |  | • Membrane traffic protein (1.3E-3) |  |